Application of the Technique of Magnetic Resonance Voxel-based Morphometry in Patients with Multiple Sclerosis before and after using High-dose Immunosuppressive Therapy with Autologous Hematopoietic Stem Cell Transplantation: Preliminary Results
暂无分享,去创建一个
Aleksandr Yu. Efimtsev | Artem G. Trufanov | A. G. Levchuk | I. A. Mashchenko | T. A. Bukkieva | E. A. Gorbunova | G. N. Bisaga | M. P. Topuzova | A. V. Fokin | A. A. Medenikov | E. D. Vyshedkevich | A. Fokin | A. Trufanov | G. Bisaga | E. Gorbunova | T. Bukkieva | A. Efimtsev | A. Levchuk | M. Topuzova | I. Mashchenko
[1] M. Sormani,et al. Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis , 2018, Multiple sclerosis.
[2] P. Stys,et al. Will the real multiple sclerosis please stand up? , 2012, Nature Reviews Neuroscience.
[3] G. Nygaard,et al. [MRI in multiple sclerosis]. , 2016, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[4] M. Kraemer,et al. Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study , 2016, International journal of molecular sciences.
[5] I. Krotenkova,et al. [Atrophy of the central nervous system in multiple sclerosis: MRI-morphometry results]. , 2014, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
[6] Christian Gaser,et al. Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients , 2017, PloS one.
[7] V. Tomassini,et al. Brain Morphometry in Multiple Sclerosis , 2018 .
[8] B. Trapp,et al. Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.
[9] W. Brück,et al. The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain , 2016, Brain : a journal of neurology.
[10] E. Luders,et al. Voxel-Based Morphometry , 2015 .
[11] C. Ferrari,et al. Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target? , 2019, Reviews in the neurosciences.
[12] Jeffrey A. Cohen,et al. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function , 2017, The Lancet.
[13] Jeffrey A. Cohen,et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.
[14] B. Sharrack,et al. Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists , 2019, Current Hematologic Malignancy Reports.
[15] D. Ramasamy,et al. Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine , 2018, American Journal of Neuroradiology.
[16] P. Matthews,et al. Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.
[17] Jeffrey A. Cohen,et al. Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] F. Jacques. Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.
[19] D. Pelletier,et al. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease , 2018, Annals of neurology.
[20] M. Ardestani,et al. A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future , 2018, Inflammation Research.
[21] Vladimir A. Fokin,et al. fMRI and Voxel-based Morphometry in Detection of Early Stages of Alzheimer's Disease , 2017, BIOIMAGING.